(S (NP (PRP We)) (VP (VBP investigate) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NP (JJ self-tracking) (NNS data)) (CC and) (NP (JJ unsupervised) (NN mixed-membership) (NNS models)))) (S (VP (TO to) (VP (VB phenotype) (NP (NN endometriosis))))))) (. .))
(S (NP (NN Endometriosis)) (VP (VBZ is) (NP (NP (NP (DT a) (JJ systemic) (, ,) (JJ chronic) (NN condition)) (PP (IN of) (NP (NP (NNS women)) (PP (IN in) (NP (JJ reproductive) (NN age)))))) (CC and) (PRN (, ,) (PP (IN at) (NP (DT the) (JJ same) (NN time))) (, ,)) (NP (NP (DT a) (ADJP (RB highly) (JJ enigmatic)) (NN condition)) (PP (IN with) (NP (NP (NP (DT no) (JJ known) (NNS biomarkers)) (SBAR (S (VP (TO to) (VP (VB monitor) (NP (PRP$ its) (NN progression))))))) (CC and) (NP (DT no) (VBN established) (NN staging))))))) (. .))
(S (NP (PRP We)) (VP (VBP leverage) (NP (NP (NNS data)) (VP (VBN collected) (PP (IN through) (NP (DT a) (JJ self-tracking) (NN app))))) (PP (IN in) (NP (NP (DT an) (JJ observational) (NN research) (NN study)) (PP (IN of) (NP (NP (NP (QP (IN over) (CD 2,800)) (NNS women)) (PP (IN with) (NP (NN endometriosis))) (VP (VBG tracking) (NP (PRP$ their) (NN condition)) (PP (IN over) (NP (NP (DT a) (NN year)) (CC and) (NP (DT a) (NN half)))))) (PRN (-LRB- -LRB-) (NP (NP (CD 456,900) (NNS observations)) (ADVP (JJ overall))) (-RRB- -RRB-))))))) (. .))
(S (NP (PRP We)) (VP (VBP extend) (NP (DT a) (JJ classical) (NN mixed-membership) (NN model)) (S (VP (TO to) (VP (VB accommodate) (NP (NP (DT the) (NNS idiosyncrasies)) (PP (IN of) (NP (NP (DT the) (NN data)) (PP (IN at) (NP (NN hand))))) (PRN (-LRB- -LRB-) (NN i.e.) (, ,) (NP (NP (DT the) (NN multimodality)) (PP (IN of) (NP (DT the) (JJ tracked) (NNS variables)))) (-RRB- -RRB-))))))) (. .))
(S (NP (PRP$ Our) (NNS experiments)) (VP (VBP show) (SBAR (IN that) (S (NP (PRP$ our) (NN approach)) (VP (VBZ identifies) (NP (NP (JJ potential) (NNS subtypes)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADJP (JJ robust) (PP (PP (IN in) (NP (NP (NNS terms)) (PP (IN of) (NP (NP (NP (NNS biases)) (PP (IN of) (NP (JJ self-tracked) (NNS data)))) (PRN (-LRB- -LRB-) (NP (NN e.g.)) (, ,) (NP (NP (JJ wide) (NNS variations)) (PP (IN in) (NP (VBG tracking) (NN frequency))) (PP (IN amongst) (NP (NNS participants)))) (-RRB- -RRB-)))))) (, ,) (CONJP (RB as) (RB well) (IN as)) (PP (TO to) (NP (NP (NNS variations)) (PP (IN in) (NP (NP (NNS hyperparameters)) (PP (IN of) (NP (DT the) (NN model))))))))))))))))) (. .))
(S (S (VP (ADVP (RB Jointly)) (VBG modeling) (NP (NP (DT a) (JJ wide) (NN range)) (PP (IN of) (NP (NP (NNS observations)) (PP (IN about) (NP (NNS participants))))) (PRN (-LRB- -LRB-) (NP (NP (NNS symptoms)) (, ,) (NP (NP (NN quality)) (PP (IN of) (NP (NN life)))) (, ,) (NP (NNS treatments))) (-RRB- -RRB-))))) (VP (NNS yields) (NP (NP (ADJP (RB clinically) (JJ meaningful)) (NNS subtypes)) (SBAR (WHNP (IN that)) (S (VP (DT both) (VP (VBP validate) (SBAR (WHNP (WP what)) (S (VP (VBZ is) (ADVP (RB already)) (VP (VBN known) (PP (IN about) (NP (NN endometriosis)))))))) (CC and) (VP (VBP suggest) (NP (JJ new) (NNS findings)))))))) (. .))
